Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or beta-lactamase-producing Haemophilus influenzae.
Acute respiratory infections with penicillin-resistant strains of Streptococcus pneumoniae and a beta-lactamase-producing strain of Haemophilus influenzae were established in neutropenic weanling rats. By use of nonsurgical intrabronchial instillation of the bacteria suspended in molten agar, reproducible, acute respiratory infections suitable for experimental antibiotic efficacy studies were established.
Smith
G M
GM
SmithKline Beecham Pharmaceuticals, Betchworth, Surrey, United Kingdom.
Abbott
K H
KH
D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D006192:Haemophilus Infections / Q000188:drug therapy / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000201:enzymology; D008168:Lung / Q000382:microbiology; D008297:Male; D009503:Neutropenia / Q000150:complications*; D010403:Penicillin Resistance / Q000502:physiology*; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D001618:beta-Lactamases / Q000096:biosynthesis*
D000658:Amoxicillin; D001618:beta-Lactamases